Logo image of ALDAR.PA

DAMARTEX (ALDAR.PA) Stock Fundamental Analysis

EPA:ALDAR - Euronext Paris - Matif - FR0000185423 - Common Stock - Currency: EUR

4.16  -0.02 (-0.48%)

Fundamental Rating

1

ALDAR gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 43 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the profitability and financial health of ALDAR have multiple concerns. ALDAR is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ALDAR had negative earnings in the past year.
ALDAR had a positive operating cash flow in the past year.
In the past 5 years ALDAR reported 4 times negative net income.
ALDAR had a positive operating cash flow in 4 of the past 5 years.
ALDAR.PA Yearly Net Income VS EBIT VS OCF VS FCFALDAR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

ALDAR's Return On Assets of -5.22% is on the low side compared to the rest of the industry. ALDAR is outperformed by 90.70% of its industry peers.
Looking at the Return On Equity, with a value of -25.81%, ALDAR is doing worse than 88.37% of the companies in the same industry.
Industry RankSector Rank
ROA -5.22%
ROE -25.81%
ROIC N/A
ROA(3y)-5.09%
ROA(5y)-4.83%
ROE(3y)-23.54%
ROE(5y)-23.61%
ROIC(3y)N/A
ROIC(5y)N/A
ALDAR.PA Yearly ROA, ROE, ROICALDAR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

The Gross Margin of ALDAR (64.44%) is comparable to the rest of the industry.
ALDAR's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ALDAR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y-0.32%
ALDAR.PA Yearly Profit, Operating, Gross MarginsALDAR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

0

2. Health

2.1 Basic Checks

ALDAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALDAR has about the same amount of shares outstanding.
Compared to 5 years ago, ALDAR has more shares outstanding
ALDAR has a worse debt/assets ratio than last year.
ALDAR.PA Yearly Shares OutstandingALDAR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALDAR.PA Yearly Total Debt VS Total AssetsALDAR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

ALDAR has an Altman-Z score of 0.74. This is a bad value and indicates that ALDAR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.74, ALDAR is doing worse than 86.05% of the companies in the same industry.
The Debt to FCF ratio of ALDAR is 5.62, which is a neutral value as it means it would take ALDAR, 5.62 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.62, ALDAR is not doing good in the industry: 60.47% of the companies in the same industry are doing better.
ALDAR has a Debt/Equity ratio of 1.59. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.59, ALDAR is not doing good in the industry: 81.40% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF 5.62
Altman-Z 0.74
ROIC/WACCN/A
WACC5.33%
ALDAR.PA Yearly LT Debt VS Equity VS FCFALDAR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ALDAR has a Current Ratio of 0.69. This is a bad value and indicates that ALDAR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ALDAR (0.69) is worse than 93.02% of its industry peers.
A Quick Ratio of 0.31 indicates that ALDAR may have some problems paying its short term obligations.
With a Quick ratio value of 0.31, ALDAR is not doing good in the industry: 93.02% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.31
ALDAR.PA Yearly Current Assets VS Current LiabilitesALDAR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

ALDAR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.73%, which is quite impressive.
The Revenue has decreased by -9.59% in the past year.
ALDAR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.97% yearly.
EPS 1Y (TTM)50.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.69%
Revenue 1Y (TTM)-9.59%
Revenue growth 3Y-11.53%
Revenue growth 5Y-5.97%
Sales Q2Q%-1.95%

3.2 Future

Based on estimates for the next years, ALDAR will show a very strong growth in Earnings Per Share. The EPS will grow by 32.09% on average per year.
The Revenue is expected to decrease by -11.92% on average over the next years. This is quite bad
EPS Next Y101.03%
EPS Next 2Y50.11%
EPS Next 3Y32.09%
EPS Next 5YN/A
Revenue Next Year-1.79%
Revenue Next 2YN/A
Revenue Next 3Y-11.92%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALDAR.PA Yearly Revenue VS EstimatesALDAR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2027 200M 400M 600M
ALDAR.PA Yearly EPS VS EstimatesALDAR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

6

4. Valuation

4.1 Price/Earnings Ratio

ALDAR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 5.46, the valuation of ALDAR can be described as very cheap.
Based on the Price/Forward Earnings ratio, ALDAR is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.04, ALDAR is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 5.46
ALDAR.PA Price Earnings VS Forward Price EarningsALDAR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

ALDAR's Enterprise Value to EBITDA is on the same level as the industry average.
97.67% of the companies in the same industry are more expensive than ALDAR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.36
EV/EBITDA 9.15
ALDAR.PA Per share dataALDAR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALDAR's earnings are expected to grow with 32.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.11%
EPS Next 3Y32.09%

0

5. Dividend

5.1 Amount

ALDAR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DAMARTEX

EPA:ALDAR (8/8/2025, 7:00:00 PM)

4.16

-0.02 (-0.48%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)07-17 2025-07-17/amc
Earnings (Next)10-16 2025-10-16
Inst Owners4.52%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap48.26M
Analysts40
Price Target5.41 (30.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)-63.84%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.46
P/S 0.09
P/FCF 1.36
P/OCF 1.09
P/B 0.54
P/tB N/A
EV/EBITDA 9.15
EPS(TTM)-2.02
EYN/A
EPS(NY)0.76
Fwd EY18.32%
FCF(TTM)3.05
FCFY73.43%
OCF(TTM)3.81
OCFY91.49%
SpS44.9
BVpS7.63
TBVpS-3.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.22%
ROE -25.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.44%
FCFM 6.8%
ROA(3y)-5.09%
ROA(5y)-4.83%
ROE(3y)-23.54%
ROE(5y)-23.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y-0.32%
F-Score5
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF 5.62
Debt/EBITDA 8.32
Cap/Depr 25.25%
Cap/Sales 1.67%
Interest Coverage N/A
Cash Conversion 260.63%
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.31
Altman-Z 0.74
F-Score5
WACC5.33%
ROIC/WACCN/A
Cap/Depr(3y)44.16%
Cap/Depr(5y)37.16%
Cap/Sales(3y)2.1%
Cap/Sales(5y)1.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.69%
EPS Next Y101.03%
EPS Next 2Y50.11%
EPS Next 3Y32.09%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.59%
Revenue growth 3Y-11.53%
Revenue growth 5Y-5.97%
Sales Q2Q%-1.95%
Revenue Next Year-1.79%
Revenue Next 2YN/A
Revenue Next 3Y-11.92%
Revenue Next 5YN/A
EBIT growth 1Y18.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year110.52%
EBIT Next 3Y20.14%
EBIT Next 5YN/A
FCF growth 1Y176.3%
FCF growth 3Y-26.44%
FCF growth 5Y28.36%
OCF growth 1Y245.85%
OCF growth 3Y-21.27%
OCF growth 5Y5.37%